Menu

Retiring Congressman to Lead AAAS

Rush Holt, a research physicist and former teacher who is leaving the US House of Representatives, will become executive publisher of the Science journals.

Nov 19, 2014
Tracy Vence

Rush HoltWIKIMEDIA, UNITED STATES CONGRESSThe American Association for the Advancement of Science (AAAS) has chosen Rush Holt (D-NJ) to succeed Alan Leshner as chief executive officer of the professional organization and executive publisher of Science and its related journals. Holt, who is retiring from the US House of Representatives at the end of his eighth term, is a research physicist and former faculty at Swarthmore College in Pennsylvania.

“Efforts to advance science, promote public engagement with science and technology, and ensure that accurate scientific information informs policy decisions—core AAAS activities—have also been central to Holt’s long record of public service,” the association said in a statement announcing Holt’s hire.

Holt, who has represented New Jersey in Congress since 1999, earned a PhD in physics from New York University in 1981. He was awarded an AAAS Science & Technology Policy Fellowship in 1982.

“I look forward to supporting the association’s mission to advance science, engineering, and innovation throughout the world, for the benefit of all people,” he said in the AAAS statement.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.